S5/10Economic

Tariff-Proof But Not China-Proof: The Geopolitics of India’s Pharma Power

Washington has spared India’s generics from its new drug tariffs. But the real exposure running through India’s pharmacy lies upstream, in China – and it is the West’s problem too.

26 Jun 2026, 14:16 UTCSource: The DiplomatOriginal source

Click a tag to subscribe via email/Telegram (manage channels in Account).

⚠️ A model estimate of cascade risk — not a guarantee and not buy/sell. Calibration uses resolved outcomes only; monitor confirmation indicators below.
A
Эскалация

Forecast derived from cascade analysis. Watch confirmation indicators below.

Horizon: 7–30 days

Exact probability, cascade chain, and confirmation indicators unlock for approved members.

Checking access status…